CFTR mutations and IVS8-5T variant in newborns with hypertrypsinaemia and normal sweat test

Journal of Medical Genetics

Volumn 34, Issue 4, 1997, Pages 297-301

  Castellani, C ^a   Bonizzato, A ^a   Mastella, G ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Cystic fibrosis; Hypertrypsinaemia; IVS8 5T variant

Indexed keywords

LACTASE; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRYPSIN;

ARTICLE; CYSTIC FIBROSIS; GENE MUTATION; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; IMMUNOREACTIVITY; NEWBORN; PRIORITY JOURNAL; RECEPTOR GENE; SWEAT TEST;

EID: 0030957131     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.34.4.297     Document Type: Article

References (26)

1. Dankert-Roelse JE. Neonatal screening. In: Dodge JA, Brock DJH, Widdicombe JH, eds. Cystic fibrosis - current topics. Chichester: Wiley, 1994:303-18.
2. Laroche D, Travert G. Abnormal frequency, of ΔF508 mutation in neonatal transitory hypertrypsinaemia. Lancet 1991;337:55.
3. Lucotte G, Perignon JL, Lenoir G. Transient neonatal hypertrypsinaemia as test for ΔF508 heterozygosity. Lancet 1991;337:988.
4. Chillon M, Casals T, Mercier B, et al. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 1995;332:1475-80.
5. Dates RD, Amos JA. The genetic basis of congenital bilateral absence of the vas deferens and cystic fibrosis. J Androl 1994;15:1-8.
6. Patrizio P, Zielenski J. Congenital absence of the vas deferens: a mild form of cystic fibrosis. Mol Med Today 1996;2:24-31.
7. Bonizzato A, Bisceglia L, Marigo M, et al. Analysis of the complete coding region of the CFTR gene in a cohort of CF patients from north-eastern Italy: identification of 90% of the mutations. Hum Genet 1995;95:397-402.
8. Cabrini G, Pederzini F, Perobelli L, Mastella G. An evaluation of an enzyme assay method for immunoreactive trypsin in dried blood spots. Clin Biochem 1990;23:213-19.
9. Pederzini F, Faraguna D, Giglio L, et al. Development of a screening system for cystic fibrosis: meconium or blood spot trypsin or both? Acta Paediatr Scand 1990;79:935-2.
10. Singer-Sam J, Tanguay RL, Riggs AD. Use of Chelex to improve the PCR signal from a small number of cells. Amplifications: a forum for PCR users 1989;3:11.
11. Walsh PS, Metzger DA, Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques 1991;10:506-13.
12. Gasparini P, Bonizzato A, Dognini M, Pignatti PR Restriction site generating polymerase chain reaction (RG-PCR) for the probeless detection of hidden genetic variation: application to the study of some common cystic fibrosis mutations. Mol Cell Probes 1992;6:1-7.
13. Rommens J, Kerem BS, Greer W, et al. Rapid nonradioactive detection of the major cystic fibrosis mutation. Am J Hum Genet 1990;46:395-6.
14. Chehab FF, Wall J. Detection of multiple cystic fibrosis mutations by reverse dot blot hybridization: a technology for carrier screening. Hum Genet 1992;89:163-8.
15. Gibson LE, Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pylocarpine by iontophoresis. Pediatrics 1959;23:544-9.
16. Dörk T, Fislage R, Neumann T, et al. Exon 9 of the CFTR gene: splice site haplotypes and cystic fibrosis mutations. Hum Genet 1994;93:67-73.
17. Kiesewetter S, Macek M Jr, Davis C, et al. A mutation in CFTR produces different phenotypes depending on chromosomal background. Nat Genet 1993;5:274-8.
18. Cuppens H, Teng H, Raeymaekers P, De Boeck C, Cassiman JJ. CFTR haplotype backgrounds on normal and mutant CFTR genes. Hum Mol Genet 1994;3:607-14.
19. Crossley JR, Elliot RB, Smith PA. Dried-blood spot screening for cystic fibrosis in the newborn. Lancet 1979;i:472-4.
20. Rock MJ, Mischler EH, Parrel PM, et al. Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels. Pediatrics 1990;85:1001-7.
21. Waters DL, Dorney SFA, Gaskin KJ, et al. Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program. N Engl J Med 1990;322:303-8.
22. Pederzini F, Cabrini G, Faraguna D, et al. Neonatal screening for cystic fibrosis using blood trypsin with complementary meconium lactase: an advisable strategy for the population of southern Europe. Screening 1995;3:173-9.
23. Giglio L, Faraguna D, Pederzini F. Neonatal screenig for cystic fibrosis: IRT false positive cases. Proceedings of the Conference on Mucoviscidose: depistage neonatale et prise en charge precoce, Caen, 1988.
24. Chu CS, Trapnell BC, Curristin S, et al. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet 1993;3:151-6.
25. Estivill X. Complexity in a monogenic disease. Nat Genet 1996;12:348-50.
26. Pignatti PF, Bombieri C, Benettazzo MG, et al. CFTR gene variant IVS8-5T in disseminated bronchiectasis. Am J Hum Genet 1996;58:889-92.